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metastatic melanoma: a clinical
and histopathological mimicker
of melanoma in situ occurring
in multiplicity
The distinction between primary melanoma and melanoma metastatic
to the skin has major prognostic implications. We report a case of a
67-year-old male with a diagnosis of a superficial spreading melanoma
(stage IB) rendered 6 years earlier who presented clinically with an
atypical nevus on his left thigh. Histopathological examination showed
an intraepidermal melanocytic proliferation that was interpreted as
melanoma in situ. Subsequently, 45 additional pigmented macules
appeared in crops over a 9-month period. Clinically and
dermoscopically, these lesions were extremely polymorphic.
Histopathological findings were compatible with melanoma in situ, as
each lesion consisted of a wholly intraepidermal proliferation of
markedly atypical melanocytes arranged singly and in nests. A complete
gastrointestinal study showed multiple pigmented metastatic lesions
throughout the stomach and small bowel, which supported a diagnosis
of metastatic melanoma with gastrointestinal and epidermotropic skin
involvement. Monosomy of chromosome 9 and a BRAF V600E
mutation were detected in the primary tumor sample and in
macro-dissected secondary lesions. No CDKN2A or CDK4 germline
mutations were found. Intraepidermal epidermotropic metastases of
melanoma have been rarely described in literature. In this case,
histopathology alone was insufficient to distinguish metastatic
melanoma from multiple in situ melanomas. The recognition of
epidermotropic metastases should be based on the correlation between
clinical, dermoscopic, histopathological and molecular findings.
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Intraepidermal epidermotropic metastatic melanoma
Cutaneous melanoma represents a lethal skin cancer
that is responsible for 80% of skin cancer mortality.1
Metastatic melanoma progression typically evolves
from local cutaneous growth to regional metastasis
involving lymph node(s) or in-transit metastasis,
and later disseminated metastatic disease may
involve skin or any visceral organ.2 Cutaneous
melanoma metastases usually involve the dermis
and subcutaneous tissue and spare the overlying
epidermis.3 Rarely, metastatic melanomas can show
prominent epidermotropism, mimicking primary
melanoma. Epidermotropic metastatic melanoma
represents a recognized pathological variant. Its
recognition is particularly challenging as its clinical
and histopathological appearance can simulate
primary melanoma.4 This distinction is crucial
in the prognosis and treatment approach to
affected patients. In 1978, Kornberg and colleagues
proposed histopathological criteria for the diagnosis
of epidermotropic metastatic melanoma,5 which are
still used at the present time. However, in the
past few decades, the morphological spectrum of
epidermotropic metastatic melanoma has broadened
and additional criteria have been added.4,6–8
Herein, we report a patient whose melanoma
recurred with 46 epidermotropic metastases that
were wholly intraepidermal. The patient also suf-
fered from multifocal asymptomatic gastrointestinal
metastases.
Case report
In 2002, a 67-year-old male was diagnosed with a
non-ulcerated superficial spreading melanoma (stage
IB, T2 N0 M0, Breslow’s thickness 1.3 mm, Clark’s
level III) involving the lower back (Fig. 1). Sentinel
lymph node evaluation was not performed. After
wide excision (1 cm), adjuvant immunotherapy with
A B
Fig. 1. Histopathology of the primary melanoma of the back, which was excised in November 2002. The proliferation was broad and
markedly asymmetrical (A: hematoxylin and eosin,×40). There was a population of atypical melanocytes with pagetoid spread and epidermal
consumption (B: hematoxylin and eosin, ×100).
Fig. 2. Histopathology of a pigmented lesion of the thigh that
appeared 6 years after the excision of the primary melanoma. There
was a wholly intraepidermal proliferation of atypical melanocytes
with pagetoid spread, indistinguishable from melanoma in situ
(hematoxylin and eosin, ×40).
interferon-alpha (3 millions IU, thrice weekly) was
started and maintained over 12 months. He was
regularly followed and remained free from disease
recurrence up until February 2009, when an
irregularly shaped and highly pigmented macule
appeared on his left thigh. His environmental
exposure history was significant for several sunburns
before 20 years of age and family history was
remarkable for melanoma in two siblings.
Histopathological examination of the new pig-
mented lesion was interpreted as melanoma in situ
(Fig. 2). Subsequently, several small pigmented mac-
ules appeared in crops on the back (Fig. 3). The most
irregular ones were excised and all biopsy specimens
showed markedly atypical melanocytes arranged in
irregular nests and solitary units at all levels of epi-
dermis, mimicking melanoma in situ. Neither dermal
involvement nor invasion of vascular or lymphatic
spaces was detected (Fig. 4). Those judgments were
supported by Melan-A and CD31 stains.
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Fig. 3. The clinical appearance of several pigmented lesions on the
back is depicted.
New crops of pigmented lesions appeared on the
back, arms and legs. Most of them were small (less
than 5 mmof diameter), brownish, well-defined, sym-
metric and macular. A total of 46 lesions were ex-
cised during a 9-month period. Histopathological
findings were similar in all specimens, consisting
of an exclusively intraepidermal proliferation of
large atypical melanocytes with increased nuclear to
cytoplasmatic ratio and prominent nucleoli. Those
findings were compatible with melanoma in situ,
although many lesions were small, symmetric and
circumscribed (Fig. 5).
Dermoscopically, the lesions were extremely poly-
morphic. Most of the excised macules had a light-
brown symmetric homogeneous pattern with only
few darker dots at the periphery. Frequently, a reg-
ular starburst pattern was also observed. In some
lesions, melanoma-specific criteria were present, par-
ticularly blue-white structures and irregular blotches
(Fig. 6).
The patient underwent staging with inguinal
nodal ultrasonography; computed tomography (CT)
of the head, chest, abdomen and pelvis; brain
magnetic resonance (MR) and positron emission
tomography/CT (PET-CT). Distant metastases
were not identified by this testing. Results of
routine laboratorial evaluation, including lactate
dehydrogenase (LDH) and S-100 protein, were
unremarkable. Mucosal and uveal involvement by
melanoma was also excluded. Even though the
patient was asymptomatic, an upper endoscopy
was performed that showed pigmented macules
and ulcerated nodules involving the stomach and
duodenum mucosa. The biopsy specimens revealed
metastatic melanoma within superficial mucosa
(Fig. 7). This diagnosis was supported by positive
immunostaining with HMB-45. Surgical resection
of the stomach and proximal duodenum was
considered, but surgery was rejected after detection
of multifocal metastatic melanoma throughout the
entire length of the jejunum and ileum by capsule
videoendoscopy.
Molecular analysis was also performed. Genomic
DNA was extracted from peripheral blood nucleated
cells using conventional procedures. No germline
point mutations or exonic rearrangements were
found in the CDKN2A gene or point mutations in
CDK4 ( codon 24). Fluorescence in situ hybridiza-
tion (FISH) analysis was completed using paraffin-
embedded sections of the primary lesion and a com-
mercially available probe to target the gene CDKN2A
in chromosome band 9p21 and the centromere of
chromosome 9 (LSI CDKN2A /CEP 9 Probe -
Vysis/Abbott). Monosomy of chromosome 9 (includ-
ing loss of a copy of the CDKN2A gene) was found
in the primary tumor. We also performed mutation
analysis of BRAF (codon 600) in paraffin-embedded
sections of the primary tumor sample and in freshly
collected biopsy specimens from seven presumed sec-
ondary lesions of the skin. A BRAF V600E mutation
was detected in the primary tumor sample but not
in the seven skin biopsy specimens analyzed. Given
this unexpected finding, we looked for monosomy
9 and BRAF codon 600 in paraffin-embedded tis-
sue sections of five distinct and separate secondary
skin lesions (molecular analysis was completed after
macrodissection to avoid contamination with normal
cells) and indeed found that the primary tumor and
all the analyzed secondary lesions shared the chro-
mosome 9 monosomy and BRAF V600E mutation.
During ongoing follow up, albeit with the con-
tinuous appearance of new pigmented lesions until
November 2009, the patient remained asymptomatic
with good general status. A multidisciplinary team
decided to delay initiation of systemic chemother-
apy and/or chemoimmunotherapy and wait for the
beginning of a new clinical trial recruiting patients
with stage IV malignant melanoma.
In February of 2010, the patient died as a result
of a large aortic thrombus with an extensive systemic
embolization affecting the brain, heart, spleen and
kidney. The patient’s family refused an autopsy.
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Fig. 4. The histopathology of a pigmented macular lesion from the lower back (April 2009) is illustrated. There is an atypical intraepidermal
melanocytic proliferation with an associated lymphocytic infiltrate in the superficial dermis (A: hematoxylin and eosin, ×40). Further detail
shows atypical melanocytes arranged in singly and in nests (B: hematoxylin and eosin, ×100).
Fig. 5. The histopathological features of a pigmented skin removed
from the right thigh (July 2009). There is a small, symmetric and
well-circumscribed lesion composed of nests of atypical melanocytes
confined to the epidermis.
Discussion
Cutaneous metastases of melanoma have a
variable appearance. Papules, nodules and tumors
commonly involve the dermis and subcutis and
less frequently involve the overlying epidermis.3
Metastases with epidermal involvement have been
designated epidermotropicmetastaticmelanoma and
usually present as multiple, symmetric, small lesions
occurring in crops located in the same region
as the primary melanoma. Less frequently, widely
disseminated lesions can be seen.3–6
Histopathological criteria for defining epider-
motropic metastatic melanoma have evolved over
the years. The distinction between metastatic and
primarymelanomawas initially based on the absence
of involvement of the overlying epithelium.9 In
1978, Kornberg and colleagues developed spe-
cific histopathological features that favored the
diagnosis of epidermotropic metastatic melanoma,
including: (a) dermal involvement equal or greater
than epidermal involvement; (b) junctional epider-
mal involvement not extending beyond the edge of
the dermal component; (c) atypical melanocytes fill-
ing the papillary dermis with thinning of epidermis;
(d) widening of papillae with the formation of an
epithelial collarette; and (e) the identification of atyp-
ical melanocytes in vascular and lymphatic spaces.5
Subsequently, epidermotropic metastatic melanoma
with pagetoid spread of atypical melanocytes beyond
the lateral limits of the dermal component of der-
mal melanoma was described.6,10,11 Several reports
also suggested that angiotropism is suggestive of
metastatic disease.7,12
Immunohistochemistry may be useful as a
tool for distinguishing epidermotropic metastatic
melanoma and multiple primary melanomas in situ,
but the approach lacks specificity: metallothionein
expression is strongly expressed by epidermotropic
metastatic melanoma but is also expressed by Spitz
nevi. In epidermotropic metastases, the intensity
of HMB-45 staining is greater than that of S-
100, but this phenotype does not exclude primary
melanoma.4,13
Abernethy et al. reported two patients with
widespread epidermotropic metastatic melanoma,
including classic lesions with intraepidermal exten-
sion beyond the intradermal component and 10
lesions with only epidermal involvement simulating
melanoma in situ.13 In contrast to previous reports,
our patient’s lesions all showed identical histopathol-
ogy with exclusively epidermal involvement and no
detectable dermal disease. In this setting, the distinc-
tion between epidermotropic metastatic melanoma
and multiple primary melanomas is virtually impos-





Fig. 6. Heterogeneous clinical and dermoscopic findings are depicted. There is a uniform diffuse brown lesion with a few darker dots
throughout and at its periphery (A). A multicomponent pattern lesion has significant asymmetry of color and structure; blue-white structures,
irregular dots and irregular blotches are seen (B). Depicted is a globular pattern lesion with variously sized dark brown globules; a blue-white
veil is also noted at the periphery (C). A regular and symmetric starburst pattern is also recognizable (D).
epidermotropic metastatic melanoma was suggested
by clues expressed by most of our patient’s lesions,
including: (a) multiple disseminated lesions appear-
ing in crops; (b) lesions of small size; and (c) lesional
symmetry and circumscription.
Regression of the dermal component is unlikely
to be the explanation of this epidermal-only pattern.
Rather, the phenomenon of epidermotropic metas-
tasis probably represents hematogenous spread with
only transient or minimal dermal involvement. The
survival of patients with melanoma is heavily depen-
dent on the stage of the malignancy, and patients
with epidermotropic metastases have a poor prog-
nosis and distant metastases involving other organs
are a frequent finding.14 PET combined with CT
imaging (PET-CT) has become a major diagnos-
tic tool in the detection of metastatic disease, as
the technique improves the identification of deep
soft tissue, lymph node and visceral metastases.15,16
PET-CT has been also proposed as the method
of choice in detecting gastrointestinal melanoma
metastases, which frequently are underdiagnosed by
standard endoscopic techniques.17,18 However, small
metastatic deposits need to achieve a certain size to
be detected by PET-CT.15 In this case, the diagnosis
of metastatic melanoma was particularly challeng-
ing. While the presence of widely disseminated small
pigmented lesions appearing in crops in a patient
with a previous diagnosis of melanoma suggested
epidermotropic metastatic melanoma as a possibil-
ity, a staging evaluation (including a PET-CT) was
negative for distant metastatic disease. In addition,
histopathology was unable to discriminate epider-
motropic metastases from multiple melanomas in situ
and dermoscopy also failed to show unequivocal
dermoscopic melanoma criteria. Indeed, few stud-
ies are available regarding the dermoscopic features
of cutaneous metastatic melanoma.19–22 In a study
with 130 cutaneous melanoma metastases, the sac-
cular and vascular patterns as well as the presence
of pigmentary halo and peripheral gray spots have
been proposed as the most significant dermoscopic
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Fig. 7. Gastrointestinal melanoma metastases are depicted. The endoscopic appearance of gastrointestinal lesions shows dark-brown macules
and ulcerated nodules. The histopathological features of a gastric melanomametastasis include a proliferation of atypical melanocytes arranged
in confluent nests in the superficial mucosa (hematoxylin and eosin, ×40); positive immunostaining with HMB-45 was also observed.
elements supporting interpretation as metastatic
melanoma.19 To the best of our knowledge, the
dermoscopic results of epidermotropic metastatic
melanoma have not been previously described. In
our case, the dermoscopic findings were polymor-
phic and included reticular, homogeneous, globular
and spitzoid patterns simulating melanocytic nevi or
primary cutaneous melanoma. These heterogeneous
findings suggest that the diagnosis of epidermotropic
metastatic melanoma cannot reliably be made on the
basis of dermoscopic features alone.
Genetic analysis of melanoma can provide addi-
tional information of use in the distinction of
metastatic lesions from independent primaries.23–26
Although genetic intra- and intertumoral hetero-
geneity is a frequent feature inmelanoma, it would be
expected that a primarymelanoma and its metastases
would share one or more genetic alterations. Loss of
heterozygosity (LOH) and X-chromosome inactiva-
tion analysis studies suggest that metastatic lesions
in most melanoma patients are clonally related to
their primary lesions.23,25,27 In our patient’s tissue,
the somatic mutation V600E in the BRAF gene
and monosomy 9 were identified in the primary
melanoma. Mutations in BRAF have been described
in 40–80% of melanomas and V600E is the most
common observed mutation. Mutations in BRAF
appear to represent an early event in melanoma
progression and are usually retained in secondary
lesions.23,28 In our case, the V600E mutation was
not initially detected in any of the seven freshly
collected metastases, which were analyzed without
macrodissection (and thus contaminating normal
tissue may have obscured the molecular results).
However, the subsequent use of FISH in paraffin-
embedded tissue sections and molecular analysis
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after macrodissection to avoid contamination
allowed the demonstration of a molecular rela-
tionship between five presumed epidermotropic
metastases and the original primary melanoma. No
evidence of hereditary predisposition associated with
germline mutations of CDKN2A or CDK4, as can be
seen in familial andmultiple primary melanoma, was
found.29,30.
We therefore conclude that the 46 pigmented
lesions affecting our patient represent intraepider-
mal epidermotropic metastatic melanoma and not
multiple examples of primary melanoma in situ.
The clinical appearance of the lesions in con-
junction with atypical dermoscopic findings, the
presence of multiple gastrointestinal metastases, and
the genetic findings strengthen this assertion. Our
case shows that histopathology alone can be insuf-
ficient to distinguish intraepidermal epidermotropic
metastatic melanoma from multiple primary lesions.
Its recognition should be based on correlation with
clinical, dermoscopic, histopathological and genetic
findings.
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